Osher Lifelong Learning Institute
Can We Use Genomics to Better Understand and Treat Cancer?
Speaker
Professor Jill Mesirov
Coordinator
Jerry Kent
The sequencing of the human genome and the
development of new methods for acquiring biological
data have changed the face of medical research. The
use of mathematical and computational approaches,
including machine learning techniques, is critical
to take advantage of this explosion in biological
information. These methods lead to the identification
of candidate compounds for new treatments and
better outcomes. Some recent discoveries resulting
from the analysis of these data and their implications
for the understanding and treatment of cancer will
be described.
development of new methods for acquiring biological
data have changed the face of medical research. The
use of mathematical and computational approaches,
including machine learning techniques, is critical
to take advantage of this explosion in biological
information. These methods lead to the identification
of candidate compounds for new treatments and
better outcomes. Some recent discoveries resulting
from the analysis of these data and their implications
for the understanding and treatment of cancer will
be described.
Speaker Bio
Presenter: Jill Mesirov is Associate Vice
Chancellor for Computational Health Sciences and
Professor of Medicine at UC San Diego Health
Sciences, responsible for the overarching strategy
for computational health sciences and research
computing at UC San Diego School of Medicine.
She is a member of the UC San Diego Moores
Cancer Center, where she serves as co-lead for
the structural and functional genomics research
program. Before moving to UC San Diego, she was
at the Broad Institute of MIT and Harvard.
She received her Ph.D. in mathematics from
Brandeis University.
Chancellor for Computational Health Sciences and
Professor of Medicine at UC San Diego Health
Sciences, responsible for the overarching strategy
for computational health sciences and research
computing at UC San Diego School of Medicine.
She is a member of the UC San Diego Moores
Cancer Center, where she serves as co-lead for
the structural and functional genomics research
program. Before moving to UC San Diego, she was
at the Broad Institute of MIT and Harvard.
She received her Ph.D. in mathematics from
Brandeis University.
21